Donald J P Pinto Selected Research

Donald J P Pinto Research Topics

9	Thrombosis (Thrombus) 01/2020 - 01/2002
1	Atrial Fibrillation 06/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2012
1	Stroke (Strokes) 06/2012
1	Venous Thromboembolism 06/2012
1	Carotid Artery Thrombosis 12/2002
1	Hemorrhage 12/2002

3	AnticoagulantsIBA 01/2020 - 12/2002
3	apixabanIBA 06/2012 - 05/2008
2	Factor Xa InhibitorsIBA 06/2012 - 12/2002
2	Factor Xa (Coagulation Factor Xa)IBA 09/2011 - 12/2003
2	1- (3- (aminomethyl)phenyl)- N- (3- fluoro- 2'- (methylsulfonyl)(1,1'- biphenyl)- 4- yl)- 3- (trifluoromethyl)- 1H- pyrazole- 5- carboxamideIBA 12/2002 - 01/2002
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2002 - 01/2002
1	EnzymesIBA 01/2020
1	pyridineIBA 01/2020
1	Factor XIa (Coagulation Factor XIa)IBA 01/2020
1	compound 21IBA 01/2016
1	edoxabanIBA 06/2012
1	RivaroxabanIBA 06/2012
1	anthranilamideIBA 05/2008
1	Blood Coagulation Factors (Coagulation Factor)IBA 08/2006
1	Peptide Hydrolases (Proteases)FDA Link 08/2006
1	pyrazoleIBA 12/2002
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2002
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2002
1	Thrombin FDA Link 12/2002
1	argatroban (MPQA)FDA Link 12/2002

1	Intravenous Administration 12/2017